Clinical Trials Logo

Contrast Media clinical trials

View clinical trials related to Contrast Media.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03806725 Withdrawn - Acute Kidney Injury Clinical Trials

Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography

Start date: June 1, 2020
Phase:
Study type: Observational

This study evaluates the safety of iodinated contrast medium administered to liver transplant candidates with decreased renal function undergoing coronary CT angiography. Incidence of post-contrast acute kidney injury in liver transplant candidates with decreased renal function and normal renal function will be compared.

NCT ID: NCT02261909 Withdrawn - Acute Kidney Injury Clinical Trials

New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients

Start date: May 2015
Phase:
Study type: Observational

NephroCheck is measuring the concentration of a certain protein combination in the urine of patients. In elevated values there is a probability of renal failure (already proven in intensive care patients). The investigators would like to investigate whether the investigators can predict renal failure in patients receiving contrast enhanced CT's in the emergency department. That would lead to an earlier nephrologist consult in those patients.

NCT ID: NCT00718055 Withdrawn - Clinical trials for Colorectal Neoplasms

Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

Start date: November 2006
Phase: Phase 4
Study type: Observational

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan